Preventing, Diagnosing, and Treating Iron Overload in MDS

You need to be logged in to continue. Please Log In or Register using the box at the top right of this page.

Release Date: May 31, 2018
Expiration Date: May 31, 2019

Expected time to complete this activity as designed: 15 minutes

There are no fees for participating in or receiving credit for this online activity.

Program Overview

When managing low-risk myelodysplastic syndromes (MDS), iron chelation therapy can be used to treat iron overload, an important and common side effect associated with blood transfusions. This activity will address key factors to consider when deciding if iron chelation therapy is appropriate, including the role of ferritin levels, current iron chelation treatment options, patient monitoring strategies, and current survival and efficacy data associated with iron chelation in MDS patients.

Target Audience

This activity is designed for multidisciplinary healthcare providers in the community setting, including hematologists, oncologists, pharmacists and other allied healthcare professionals who provide care to patients with myelodysplastic syndromes.

Learning Objectives

Upon completion of this educational activity, participants should be able to:

  • Explain the importance of iron chelation therapy in patients with MDS
  • Identify patients with MDS for whom iron chelation therapy is appropriate
  • Describe the efficacy and safety of therapies used for iron chelation therapy in patients with MDS


Preventing, Diagnosing, and Treating Iron Overload in MDS – Azra Raza, MD

Instructions for Participation and Credit

This activity is eligible for credit through May 31, 2019. After this date, this activity will expire and no further credit will be awarded.

  1. Read the target audience, learning objectives, and faculty disclosures.
  2. You may be asked to complete a short pre-test before accessing the educational content. This must be completed in order to move forward in the activity.
  3. Complete the educational content as designed.
  4. Complete the post-test. To receive a certificate, you must receive a passing score of 70%.
  5. Complete the activity evaluation survey to provide feedback and information useful for future programming.
  6. Certificates for CME may be printed immediately after successfully completing the post-test and activity evaluation. Pharmacist credit will be uploaded to CPE Monitor 4 weeks following receipt of a completed, qualified form.

Faculty Biography

Azra Raza, MD
Professor of Medicine
Director, MDS Center
Columbia University Medical Center
New York, New York

Dr. Azra Raza completed her medical education in Pakistan, trained in internal medicine at the University of Maryland, Franklin Square Hospital, and Georgetown/VA Medical Center in Washington, DC, followed by a fellowship in medical oncology at Roswell Park Cancer Institute in Buffalo, New York. She is the Chan Soon-Shiong Professor of Medicine and Director of the MDS Center at Columbia University in New York. Previously, she was the Chief of Hematology/Oncology and the Gladys Smith Martin Professor of Oncology at the University of Massachusetts.

An international authority on pre-leukemia (MDS) and acute leukemia, Dr. Raza is one of those rare physician-scientists who divides her time equally between caring for patients and supervising a state-of-the-art basic research lab which is funded by grants. She started collecting blood and marrow samples on her patients in 1984, and now her Tissue Bank, the largest and oldest in the country with more than 60,000 samples, is considered a unique national treasure. Dr. Raza has published hundreds of original clinical and basic research peer-reviewed manuscripts in journals including Nature, The New England Journal of Medicine, Cell, Molecular Cell, Cancer Research, Blood, and Leukemia. In addition, she has published more than 1,000 abstracts, dozens of book chapters, and edited a book devoted to MDS.

Dr. Raza is a sought-after speaker in scientific circles and the recipient of numerous awards including The Hope Award in Cancer Research 2012. She was named as one of the 100 Women Who Matter by Newsweek Pakistan. She is also a member of the Founder Group designing breakthrough developments in science and technology, and the Cancer Moonshot initiative.


Accreditation Statement: MediCom Worldwide, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation Statement: MediCom Worldwide, Inc. designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
MediCom Worldwide, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity is acceptable for 0.25 contact hours of Continuing Education Credit. Universal Activity Number: 827-0000-18-012-H01-P. Knowledge-based CPE activity.

In order for CPE Monitor to authenticate credit, pharmacists/technicians must provide their e-Profile ID number from NABP and date of birth (in MMDD format) when claiming credit for a CPE program.


As an organization accredited by the Accreditation Council for Continuing Medical Education (ACCME), Accreditation Council for Pharmacy Education (ACPE) and California State Board of Registered Nursing, MediCom Worldwide, Inc. requires everyone who is in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines “relevant financial relationships” as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest. Accordingly, the following disclosures were made.

Faculty Disclosure

Dr. Azra Raza has received honoraria related to speakers’ bureau activities from Novartis AG. She has received grant support related to research activities from Celgene Corporation.

Planning Committee Disclosures

The individuals listed below from MediCom Worldwide, Inc. reported the following for this activity: Kristin Burke, Project Manager, Keith D’Oria, Medical Writer, and Joan Meyer, RN, MHA, Executive Director, have no relevant financial relationships.

Peer Reviewer Disclosure

In accordance with MediCom Worldwide, Inc. policy, all content is reviewed by external independent peer reviewers for balance, objectivity and commercial bias. The peer reviewers have no relevant financial relationships to disclose.

If you have any questions or concerns regarding this activity, please contact MediCom Worldwide, Inc. at 1-800-408-4242 or email us at

Provided by MediCom Worldwide, Inc.
This activity is supported by educational grants from Celgene Corporation and Onconova Therapeutics Inc.

©2018 MediCom Worldwide, Inc., 101 Washington St., Morrisville, PA 19067, 800-408-4242.
No portion of this material may be copied or duplicated without the expressed permission of MediCom Worldwide, Inc.

You need to be logged in to continue. Please Log In or Register using the box at the top right of this page.